Spastin anticorps (full length)
Aperçu rapide pour Spastin anticorps (full length) (ABIN7879072)
Antigène
Voir toutes Spastin (SPAST) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- full length
-
Fonction
- Spastin Antibody
-
Purification
- Protein G affinity chromatography
-
Immunogène
- Recombinant full length human Spastin protein was used as the immunogen for the Spastin antibody.
-
Isotype
- IgG2a, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the Spastin antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the Spastin antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Spastin (SPAST)
-
Autre désignation
- Spastin
-
Sujet
- The AAA protein family members share an ATPase domain and have roles in various cellular processes including intracellular motility, membrane trafficking, proteolysis, protein folding and organelle biogenesis. Spastin, a member of the AAA protein family, is a 616 amino acid protein and is involved in the function or assembly of nuclear protein complexes. The Spastin protein is expressed ubiquitously and localizes to the nucleus and the cytoplasm, where it may also be involved in microtubule dynamics. Mutations in the Spastin gene (SPAST, SPG4) cause the most common form of spastic paraplegia 4, an autosomal dominant form of hereditary spastic paraplegia (HSP). HSPs comprise a group of inherited neurological disorders characterized by spastic lower extremity weakness due to a length-dependent, retrograde axonopathy of corticospinal motor neurons. SPAST-specific mutations account for approximately 40 % of all autosomal dominant HSPs.
-
Pathways
- Dynamique des Microtubules, M Phase, Regulation of Cell Size
Antigène
-